Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAlumasc Group Regulatory News (ALU)

Share Price Information for Alumasc Group (ALU)

Share Price is delayed by 15 minutes
Get Live Data
240.00    5.00 (2.13%)
Bid:
235.00
Ask:
245.00
Spread: 10.00 (4.255%)
Market Cap: £86.30m
ALU Live PriceLast checked at - London Stock Exchange

Intraday Alumasc Group Share Chart

Trading Statement

15 Jul 2011 07:00

RNS Number : 4487K
Alumasc Group PLC
15 July 2011
 



 

For release 7am, 15 July 2011

 

THE ALUMASC GROUP PLC - TRADING UPDATE

 

The Alumasc Group plc (ALU:L), the premium building and engineering products company, is providing a trading update relating to the year ended 30 June 2011.

 

Group revenues are expected to be in line with previous expectations. However, margins in the Building Products division for the fourth quarter were significantly lower than expected as a result of rising input costs that could not be recovered fully from customers, against a background of continued weakness in the UK construction market. In particular, the group's Construction Products business experienced a 20% increase in steel costs towards the end of the financial year, with profitability further diluted by an increase in the proportion of lower margin export sales. Consequently, underlying group profit for the full year is expected to be ahead of last year, but below previous management expectations.

 

Net cash flow performance to the year end continued to be robust and remained ahead of expectations.

 

Alumasc Precision recovered strongly during the year, benefiting from international demand for aluminium components used mainly in off-highway diesel engines, and particularly those used in mining and construction vehicles being sold into emerging economies. In view of the strong resurgence at Alumasc Precision over the last eighteen months and the encouraging future prospects for this business, the impairment charge booked in 2009 is to be reversed. This will give a one-off, non-cash gain of £1.2 million in the financial year just ended. As a consequence, the group's statutory profit before tax is expected to exceed underlying profit, and be well ahead of the prior year statutory result.

 

This impairment charge reversal will increase the book value of plant and equipment and therefore give rise to a higher depreciation charge of £0.3 million per annum in the 2011/12 financial year and beyond.

 

There is early evidence that a greater number of large buildings are now beginning to be funded, which could benefit Levolux, in particular, in the group's 2012/13 financial year. This is broadly consistent with external construction industry forecasts as to the expected timing of a return to growth. In the meantime, export sales strategies are beginning to add incrementally to Alumasc's revenues, and there are numerous initiatives across the group to mitigate the impact of the specific current weakness in the UK commercial new build sector, diversify routes to market and introduce new and innovative products.

 

Alumasc Precision continues to grow, although it is anticipated that growth will be at a more sustainable rate whilst the business prepares for the next phase of the project won last October to supply components for larger engine transmission systems, expected to start late in 2012.

 

In view of the continued strong group order book at Alumasc Precision, and the factors outlined above, the Board expects Alumasc to continue to make steady progress in 2011/12.

 

The Board will review the group dividend ahead of the announcement of its full year results in September in the light of current trading and future prospects at that time.

 

The results for the year ended 30 June 2011 will be announced on Tuesday, 6th September 2011. A presentation to analysts will be made at 9.30am on that day, at the offices of Peel Hunt, 111 Old Broad Street, London EC2N 1PH.

 

Enquiries:

 

The Alumasc Group plc

Paul Hooper (Group Chief Executive) Tel: 01536 383821

Andrew Magson (Group Finance Director) Tel: 01536 383844

 

Bankside Consultants

Simon Bloomfield or James Irvine-Fortescue Tel: 0207 367 8861

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFADAISLIL
Date   Source Headline
20th Sep 201911:29 amRNSNotice of AGM
20th Sep 20197:00 amRNSDirectorate Change
11th Sep 201912:10 pmRNSDirector/PDMR Shareholding
5th Sep 20197:00 amRNSDirectorate Changes
5th Sep 20197:00 amRNSFull Year Results
17th Jul 201910:52 amRNSNotice of Results
28th Jun 201911:00 amRNSUpdate on Levolux strategy
25th Jun 20197:00 amRNSAIM Admission
21st Jun 20198:00 amRNSSchedule One update - The Alumasc Group Limited
20th Jun 20195:30 pmRNSAlumasc Group
14th Jun 20197:00 amRNSTrading Update
3rd Jun 20199:24 amRNSTotal Voting Rights
23rd May 201911:55 amRNSResult of General Meeting
9th May 20193:53 pmRNSDirector/PDMR Shareholding
3rd May 20192:37 pmRNSDirector/PDMR Shareholding
30th Apr 20193:00 pmRNSSchedule One - The Alumasc Group plc
26th Apr 20197:00 amRNSPROPOSED ADMISSION TO TRADING ON AIM
23rd Apr 201910:13 amRNSDirector/PDMR Shareholding
23rd Apr 201910:13 amRNSDirector/PDMR Shareholding
28th Mar 20199:51 amRNSDirector/PDMR Shareholding
5th Feb 20193:03 pmRNSDirector/PDMR Shareholding
31st Jan 20197:00 amRNSHalf-year Report
15th Jan 20197:00 amRNSBoard Changes
14th Jan 20191:30 pmRNSInterim Results Announcement Date
19th Dec 201810:30 amRNSChange of auditor
26th Nov 201811:14 amRNSDirector/PDMR Shareholding
8th Nov 201811:30 amRNSDirector/PDMR Shareholding
8th Nov 201811:26 amRNSDirector/PDMR Shareholding
2nd Nov 20187:00 amRNSAppointment of Non-Executive Director
1st Nov 20187:00 amRNSSale of Facades Business
25th Oct 20184:48 pmRNSResults of AGM
25th Oct 20187:00 amRNSAGM trading update
25th Oct 20187:00 amRNS2018 AGM Trading Statement
11th Sep 20187:00 amRNSFULL YEAR RESULTS ANNOUNCEMENT
21st Aug 20189:26 amRNSNotice of Results
2nd Jul 20182:39 pmRNSDirectorate Change
24th May 20182:54 pmRNSDirector/PDMR Shareholding
15th May 20187:00 amRNSTrading Statement
4th Apr 20181:55 pmRNSDirector/PDMR Shareholding
28th Mar 201812:12 pmRNSHolding(s) in Company
22nd Mar 20184:50 pmRNSDirector/PDMR Shareholding
22nd Mar 20189:16 amRNSDirector/PDMR Shareholding
22nd Mar 20189:15 amRNSDirector/PDMR Shareholding
20th Mar 20182:05 pmRNSDirector/PDMR Shareholding
14th Mar 20187:00 amRNSTrading Statement
23rd Feb 20189:30 amRNSHolding(s) in Company
15th Feb 201810:31 amRNSDirector/PDMR Shareholding
15th Feb 201810:30 amRNSDirector/PDMR Shareholding
12th Feb 20183:00 pmRNSDirector/PDMR Shareholding
12th Feb 20183:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.